As per Market Industry Reports (MIR) research findings, automated, standardized, scalable, integrated tumor ablation solutions set to open new avenues for stakeholders.

Over the past 15 years, the pharmaceuticals industries have undergone dramatic changes. Rising geriatric population and increasing number of cancer patients as well as advancement in tumor ablation treatment technology are the factors propelling the growth of the global tumor ablation market.

Get FREE Sample Copy with TOC to understand the structure of the complete report @

The tumor ablation market is a structured market and is largely governed by prominent players such as Integra LifeSciences Corporation, Medtronic, , AngioDynamics, NeuWave Medical, Inc. (Johnson and Johnson Services, Inc.), Galil Medical Inc. (BTG International Ltd), Boston Scientific Corporation, Misonix, HealthTronics, Inc., Sonacare Medical and MERMAID MEDICAL A/S among others.

The incidence of cancer is increasing with ageing. Around 60% of all cancer cases are diagnosed in patients aged 65 and above. For the aged patients, who are not qualified for surgery and for whom chemotherapy is not a suitable option, there are technologies such as Radiofrequency Ablation (RFA), Microwave ablation (MWA) and Cryoablation to treat their cancer. This is expected to propel the growth of the tumor ablation market.

Technological advancements have also played a key role in shaping the growth of the tumor ablation market. For instance, in Jan 2016, launched OsteoCool RF Ablation System a product equipped with cooled radiofrequency (RF) ablation technology.


By Technology

  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • High Intensity Focused Ultrasound (HIFU))
  • Other Technologies

To Purchase this Report Click @

By Mode of Treatment

  • Surgical Ablation
  • Laparoscopic Ablation
  • Percutaneous Ablation

By Application

  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Bone Metastasis
  • Breast Cancer
  • Prostate Cancer
  • Other Cancer

By End User

  • Hospitals
  • Cancer Specialty Centers

From a regional perspective Asia Pacific is expected to witness highest CAGR in the next few years due to higher population growth and developing healthcare sector. North America commands the largest share of the tumor ablation market. The large share of this market segment can be attributed to the rising demand for minimally invasive treatment and the ongoing technological advancements. According to American Cancer Society, around 1.7 million people were diagnosed with cancer most common being breast cancer with around 0.25 million cases and lung cancer with around 0.23 million cases.


  • Deep-rooted quantitative and qualitative insights at segment and sub-segment level
  • Global insights with country levels information
  • Comprehensive insights on market dynamics, and business environment
  • Exhaustive coverage on competitive landscape
  • Access to ‘Latest Strategic Developments’ registered by leading players of the market

For deep rooted insights on this topic, please visit @


  • Technological Advancements
  • Free addition of ‘Company Profiles’
  • Clientele Base Assessment


Market Industry Reports is a global leader in market measurement and advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics and hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.


502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001,Maharashtra, India
[email protected]
+1 347 767 5477 ( US )
+44 131 463 4161 ( UK )
+ 91 8956 767 535 ( IN )

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Tumor Ablation Market 2019 Emerging Trends & Top Players Analysis 2030: Galil Medical Inc, Sonacare Medical, NeuWave Medical, AngioDynamics, Medtronic